Nippon Telegraph and Telephone had 160 patents in digitalization during Q4 2023. The patents filed by Nippon Telegraph and Telephone Corp in Q4 2023 include a system for monitoring patient medication administration and response, a registration terminal for a distributed ledger network, a related information presentation server for lectures, a system for associating character information with dialogue drawings, and an optimization device for digital twin systems. These inventions aim to improve efficiency and accuracy in various technological fields. GlobalData’s report on Nippon Telegraph and Telephone gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Nippon Telegraph and Telephone grant share with digitalization as a theme is 51% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Patient follow-up research support system, patient follow-up research support method, support control apparatus, terminal device, and program storage medium (Patent ID: US20230420086A1)
The patent filed by Nippon Telegraph and Telephone Corp. describes a patient follow-up research support system that involves a terminal device and a support control apparatus communicating via a network. The terminal device is responsible for registering administration completion information and transmitting it along with unique patient identification to the support control apparatus. The support control apparatus then processes this information to extract research target persons based on preset conditions, request responses from the terminal device, estimate patient condition changes post-medication administration, and output the results. Additionally, the system can incorporate medical care information and consent confirmation data to enhance the research support process.
Furthermore, the support control apparatus is equipped with various processing sections to handle administration completion information, request responses, acquire response data, and analyze patient condition changes. It can also estimate harmful reactions, determine the need for medical care, provide incentives to patients who consent to data use, and execute consent confirmation processes. The terminal device, on the other hand, focuses on registering administration completion information and transmitting response data to the support control apparatus. Overall, the system aims to streamline patient follow-up research by efficiently collecting and analyzing data related to medication administration and patient conditions, ultimately improving healthcare outcomes.
To know more about GlobalData’s detailed insights on Nippon Telegraph and Telephone, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
